Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 25, 2024 4:00 P.M.
Form: S-3
CIK: 0001737287
Company Name: Allogene Therapeutics, Inc.
File Number: 333-277951